A small case series associates elevated TnT levels with laboratory results and mortality.
The impact of SARS-CoV-2 on the heart is just emerging. In a single-center case series, physicians from Wuhan City, China, report on their experience with 187 patients hospitalized with COVID-19, who were admitted from January 23 to February 23, 2020; 69 patients had been excluded because of incomplete data.
The mean age of the patients was 58, and about half were women. The mean length of stay was 17 days. The rates of prior hypertension, coronary heart disease, and cardiomyopathy were 33%, 11%, and 4%, respectively. The death rate was 23%. On admission, none of the patients had an acute myocardial infarction.
Of the study sample, 28% had an elevated troponin T (TnT) level, which was defined as above the 99th-percentile upper reference limit…
Reviewing Author
DisclosuresConsultant/Advisory BoardUnited Healthcare; Element Science; Eyedentifeye, F-Prime
EquityHugo Health; Refactor Health; Element Science
Grant/Research SupportPfizer; Agency for Healthcare Research and Quality; Janssen Research and Development, National Institute of Biomedical Imaging and Engineering; National Heart, Lung, and Blood Institute; Centers for Disease Control and Prevention; National Cancer Institute; American Heart Association
DisclosuresConsultant/Advisory BoardUnited Healthcare; Element Science; Eyedentifeye, F-Prime
EquityHugo Health; Refactor Health; Element Science
Grant/Research SupportPfizer; Agency for Healthcare Research and Quality; Janssen Research and Development, National Institute of Biomedical Imaging and Engineering; National Heart, Lung, and Blood Institute; Centers for Disease Control and Prevention; National Cancer Institute; American Heart Association